CN110218691A - One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application - Google Patents

One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application Download PDF

Info

Publication number
CN110218691A
CN110218691A CN201910425792.XA CN201910425792A CN110218691A CN 110218691 A CN110218691 A CN 110218691A CN 201910425792 A CN201910425792 A CN 201910425792A CN 110218691 A CN110218691 A CN 110218691A
Authority
CN
China
Prior art keywords
seq
plasmid
ptarget
gene
primer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910425792.XA
Other languages
Chinese (zh)
Inventor
马江锋
储乐乐
方艳
信丰学
董维亮
章文明
陈可泉
姜岷
欧阳平凯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Priority to CN201910425792.XA priority Critical patent/CN110218691A/en
Publication of CN110218691A publication Critical patent/CN110218691A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/20Aspartic acid; Asparagine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y203/00Acyltransferases (2.3)
    • C12Y203/03Acyl groups converted into alkyl on transfer (2.3.3)
    • C12Y203/03003Citrate (Re)-synthase (2.3.3.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/01Hydro-lyases (4.2.1)
    • C12Y402/01002Fumarate hydratase (4.2.1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y403/00Carbon-nitrogen lyases (4.3)
    • C12Y403/01Ammonia-lyases (4.3.1)
    • C12Y403/01001Aspartate ammonia-lyase (4.3.1.1), i.e. aspartase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y403/00Carbon-nitrogen lyases (4.3)
    • C12Y403/02Amidine-lyases (4.3.2)
    • C12Y403/02001Argininosuccinate lyase (4.3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y603/00Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/05Carbon-nitrogen ligases with glutamine as amido-N-donor (6.3.5)
    • C12Y603/05004Asparagine synthase (glutamine-hydrolyzing) (6.3.5.4)

Abstract

The invention discloses the genetic engineering bacterium that one plant synthesizes altheine, classification naming is Escherichia coli △ fumABC △ arcA △ ptsG △ gltA △ argG/pAA, and deposit number is CCTCC NO:M2019170.Its building process includes knocking out starting strain fumarase encoding gene, DNA transcription in conjunction with regulatory factor encoding gene, glucose transport related gene, citrate synthase encoding gene and argininosuccinate synthetase encoding gene.Aspartic acid enzyme coding gene and asparagine synthetase A encoding gene are cloned on expression plasmid simultaneously, and by the recombinant plasmid transformed into the recombination bacillus coli for having knocked out gene before, obtain purpose bacterial strain.Altheine is synthesized using the engineering bacteria fermentation, realizes the route for using glucose to prepare altheine for raw material biosynthesis completely, efficient, green, environmental protection are economical.

Description

One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application
Technical field
The invention belongs to genetic engineering and fermentation engineering fields, and in particular to one plant utilizes glucose biological synthesis system The genetic engineering bacterium and its construction method of standby altheine and application.
Background technique
Altheine is the hydroxyamide compounds of L-Aspartic acid, be widely used in food, medicine, chemical industry synthesis and The fields such as microculture.In terms of medicine, mainly as one of 20 kinds in amino acid transfusion, and there is treatment skin disease The effect of;In terms of food, it can be used as food additives for cold drink;Chemical industry mainly do molysite stabilizer and The film of ceramic surface;In the important source material that environmental protection industry (epi) is membrane for water treatment;Meanwhile it is also microculture and zooblast Cultivate important additive.With good market prospects.
The production of altheine at present is mainly raw material through being esterified ammonolysis using L-Aspartic acid, is refined, but its mistake Journey product yield is relatively low, and is related to a large amount of organic solvent, and pollution is big, and waste water is difficult.Bioanalysis, which has, reacts mild, conversion The advantages that rate is high, the three wastes are easy to handle, is the optimal production method of altheine.The monosaccharide such as glucose, xylose derive from can be again Raw biomass resource, abundance, screening or building, which obtain one plant, to prepare L- asparagus fern by fermentation method biosynthesis The production bacterial strain of amide has great importance.The present invention is based on this to construct the bacterium with high-performance bio synthesis altheine Strain can make full use of carbon source, reduce and be lost, while improving fermentating culturing process, increase the conversion ratio of target product, reach To efficient, green, environmentally friendly purpose, there is significant meaning.
Summary of the invention
The present invention claims the genetic engineerings that plant height effect biosynthesis altheine is to provide the technical issues of solution Bacterium, classification naming are Escherichia coli △ fumABC △ arcA △ ptsG △ gltA △ argG/pAA.
The present invention also technical problems to be solved are to provide the construction method of said gene engineering bacteria, knock out starting strain Fumarase encoding gene fumABC, DNA transcription combine regulatory factor encoding gene arcA, glucose transport related gene PtsG, citrate synthase encoding gene gltA and argininosuccinate synthetase encoding gene argG, while by Aspartase Encoding gene aspA and asparagine synthetase A encoding gene asnA is cloned into expression and constitutes recombinant plasmid, and is converted To the Escherichia coli starting strain for having knocked out fumABC gene, the genetic engineering bacterium, the deposit number of the starting strain are obtained For CCTCC NO:M 2018521, the fumA gene order is as shown in SEQ ID NO:1, the fumB gene order such as SEQ Shown in ID NO:2, the fumC gene order is as shown in SEQ ID NO:3, the aspA gene order such as SEQ ID NO:4 institute Show, for the asnA gene order as shown in SEQ ID NO:5, the arcA gene order is described as shown in SEQ ID NO:6 PtsG gene order is as shown in SEQ ID NO:7, and the gltA gene order is as shown in SEQ ID NO:8, the argG gene For sequence as shown in SEQ ID NO:9, the knockout of gene uses general CRISPR/Cas9 technology.Specific building and selection It is as follows:
(1) it is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:11 as primer, plasmid pTarget F is Template, PCR amplification obtain linear fragment 1;
(2) it is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:12 as primer, repeats step (1) and obtain Linear fragment 2;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:13 as primer, repeats step (1) and obtain Linear fragment 3;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:14 as primer, repeats step (1) and obtain Linear fragment 4;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:15 as primer, repeats step (1) and obtain Linear fragment 5;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:16 as primer, repeats step (1) and obtain Linear fragment 6;
(3) it will be attached after the SpeI digestion of linear fragment 1, and product after connection be transformed into competence, be coated with The LB flat screen of spectinomycin selects positive recombinant;
(4) numerous rear progress plasmid extraction is expanded into the LB liquid training that positive recombinant is inoculated in addition spectinomycin, obtains PTarget T1-1 plasmid;
(5) transformation and selection will be attached after the SpeI digestion of linear fragment 2 and goes out positive recombinant and carry out plasmid extraction, obtain Obtain pTarget T1-2 plasmid;Transformation and selection being attached after the SpeI digestion of linear fragment 3 and going out positive recombinant carry out matter Grain extracting, obtains pTarget T1-3 plasmid;Go out positive restructuring for transformation and selection is attached after the SpeI digestion of linear fragment 4 Son carries out plasmid extraction, obtains pTarget T1-4 plasmid;Go out transformation and selection is attached after the SpeI digestion of linear fragment 5 Positive recombinant carries out plasmid extraction, obtains pTarget T1-5 plasmid;It will be attached and turn after the SpeI digestion of linear fragment 6 Change filters out positive recombinant and carries out plasmid extraction, obtains pTarget T1-6 plasmid;
(6) it is arranged with nucleotides sequence shown in SEQ ID NO:17 and SEQ ID NO:18 as primer, genome of E.coli For template, PCR amplification obtains linear fragment 7;It is to draw with the column of nucleotides sequence shown in SEQ ID NO:19 and SEQ ID NO:20 Object, genome of E.coli are template, and PCR amplification obtains linear fragment 8;
(7) it is arranged with nucleotides sequence shown in SEQ ID NO:17 and SEQ ID NO:20 as primer, segment 7 and segment 8 Mixture is template, and over-lap PCR expands to obtain linear fragment 9;
(8) dephosphorylation carries out lucky cloth with segment 9 as carrier after using EcoRI to linearize pTarget T1-1 plasmid Gloomy one-step cloning selects positive recombinant with the LB flat screen of spectinomycin;
(9) numerous rear progress plasmid pumping is expanded into the LB liquid training that the positive recombinant in step (8) is inoculated in addition spectinomycin It mentions, obtains pTarget T2-1 plasmid;
It (10) is that primer repeats step (6) to step with the column of nucleotides sequence shown in SEQ ID NO:21-SEQ ID NO:24 Suddenly (9) obtain pTarget T2-2 plasmid;With the column of nucleotides sequence shown in SEQ ID NO:25-SEQ ID NO:28 for primer weight Multiple step (6) to step (9) obtain pTarget T2-3 plasmid;With nucleosides shown in SEQ ID NO:29-SEQ ID NO:32 Acid sequence is that primer repeats step (6) to step (9) acquisition pTarget T2-4 plasmid;With SEQ ID NO:33-SEQ ID Nucleotides sequence shown in NO:36 is classified as primer and repeats step (6) to step (9) acquisition pTarget T2-5 plasmid;With SEQ ID Nucleotides sequence shown in NO:37-SEQ ID NO:40 is classified as primer and repeats step (6) to step (9) acquisition pTarget T2-6 Plasmid;
(11) pCas plasmid is imported in the starting strain that deposit number is CCTCC NO:M 2018521, with kanamycins LB flat screen selects positive recombinant;
(12) positive recombinant in step (11) is induced with arabinose, is prepared as competence;
(13) by the competence of pTarget T2-1 plasmid steps for importing (12), with addition spectinomycin and kanamycins LB flat screen select positive recombinant;
(14) positive recombinant in step (13) is identified with the method for PCR, filters out aimed strain, and use PTarget T2-1 plasmid is eliminated in IPTG induction, obtains bacterial strain 1.
(15) bacterial strain 1 in step (14) is induced with arabinose, is prepared as competence;
(16) by the competence of pTarget T2-2 plasmid steps for importing (15), with addition spectinomycin and kanamycins LB flat screen select positive recombinant;
(17) positive recombinant in step (16) is identified with the method for PCR, filters out aimed strain, and use PTarget T2-2 plasmid is eliminated in IPTG induction, obtains bacterial strain 2.
(18) pTarget T2-3 plasmid, pTarget are imported in batches with the method for similar step (15) to step (17) T2-4 plasmid, pTarget T2-5 plasmid, pTarget T2-6 plasmid carry out gene knockout, and are eliminated and imported using IPTG induction Plasmid obtains gene knock-out bacterial strain Escherichia coli △ fumABC △ arcA △ ptsG △ gltA △ argG;
(19) it is arranged with nucleotides sequence shown in SEQ ID NO:41 and SEQ ID NO:42 as primer, genome of E.coli For template, PCR amplification obtains linear fragment 10;It is to draw with the column of nucleotides sequence shown in SEQ ID NO:43 and SEQ ID NO:44 Object, genome of E.coli are template, and PCR amplification obtains linear fragment 11;
(20) it is arranged with nucleotides sequence shown in SEQ ID NO:41 and SEQ ID NO:44 as primer, segment 10 and segment 11 Mixture be template, over-lap PCR expands to obtain linear fragment 12;
(21) dephosphorylation is as carrier after using EcoRI and HindIII to linearize pTrc99a plasmid, with segment 11 into Row Ji Busen one-step cloning selects positive recombinant with the LB flat screen of the resistance of benzyl containing ammonia;
(22) numerous rear progress plasmid is expanded into the LB liquid training that the positive recombinant in step (21) is inoculated in addition spectinomycin Extracting obtains pTrc99A-asnA-aspA recombinant plasmid;
(23) gene knock-out bacterial strain in step (18) is prepared as competence;By the pTrc99A- in step (22) AsnA-aspA plasmid is converted into competence, is selected positive recombinant with the LB flat screen of the resistance of benzyl containing ammonia, is obtained target gene Engineered strain.
The last technical problems to be solved of the present invention are to provide said gene engineering bacteria in biosynthesis altheine Application.
The engineering strain of above-mentioned high-performance bio synthesis altheine prepares the specific fermented and cultured of altheine Process is as follows:
(S1) coli strain that genetic engineering is transformed is transferred in LB culture medium, 10~12h of aerobic culture is obtained Primary seed solution;
(S2) primary seed solution is transferred in fermentor LB culture medium and is cultivated, obtain secondary seed solution;
(S3) when secondary seed solution OD600 to 8.5, fermentation medium is inoculated, inoculates fermentation medium, institute The formula for stating fermentation medium is as follows:
M9 culture medium: (NH4)2SO46g/L, Na2HPO4·12H2O 15.2g/L, KH2PO43g/L, NaCl0.5g/L, NH4Cl 1g/L, MgSO42mM, CaCl20.1mM, 100g/L glucose, 0.3mM IPTG.
(S4) glucose 30g/L transformation stage fed-batch fermentation: is added after induction period.
In step (S1) and (S2), cultivation temperature is 35~37 DEG C, uses aerobic fermentation mode in step (S3) and (S4), Dissolved oxygen be 5~40% and fermentation process in temperature be 28~30 DEG C, incubation pH is adjusted to 7.0 with ammonium hydroxide.
The beneficial effects of the present invention are: innovative being constructed by way of gene knockout of the present invention is using glucose Raw material biology prepares the strain of altheine, and enhancing bacterial strain TCA recycles flux, inhibits fumaric acid synthesizing apple acid, reduces L- The consumption of aspartic acid achievees the purpose that increase L-Aspartic acid accumulation, then by aspartic acid enzyme coding gene aspA and asparagus fern Amide synthetase A encoding gene asnA is cloned on expression plasmid, while improving fermentating culturing process, is solved in biosynthesis The problem of ATP is supplied, finally improves the yield of altheine, the generation of by-product is effectively reduced, and has significant economical Property and social benefit, process route green, environmental protection.
Biomaterial of the present invention, classification naming Escherichia coli △ fumABC △ arcA △ ptsG △ gltA △ argG/pAA, has been preserved in China typical culture collection center (abbreviation CCTCC), deposit number are as follows: CCTCC NO:M 2019170, preservation date are as follows: on March 18th, 2019, preservation address are as follows: the Chinese Wuhan Wuhan University.
Specific embodiment
According to following embodiments, the present invention may be better understood.However, as it will be easily appreciated by one skilled in the art that real It applies content described in example and is merely to illustrate the present invention, without sheet described in detail in claims should will not be limited Invention.
Embodiment 1
This example demonstrates that utilizing target matter of the overlapping pcr building comprising gene targeting sequence and homologous recombination segment Grain pTarget T2-1, pTarget T2-2, pTarget T2-3, pTarget T2-4, pTarget T2-5, pTarget The method of T2-6.
1, it is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:11 as primer, plasmid pTarget F is Template, PCR amplification obtain linear fragment 1;
2, it is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:12 as primer, repeats step 1 and obtain line Property segment 2;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:13 as primer, repeats step 1 and obtain linearly Segment 3;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:14 as primer, repeats step 1 and obtain linear piece Section 4;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:15 as primer, repeats step 1 and obtain linear fragment 5;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:16 as primer, repeats step 1 and obtain linear fragment 6;
3, it will be attached after the SpeI digestion of linear fragment 1, and product after connection be transformed into competence, coating is big The LB flat screen of miromycin selects positive recombinant;
4, numerous rear progress plasmid extraction is expanded into the LB liquid training that positive recombinant is inoculated in addition spectinomycin, obtains PTarget T1-1 plasmid;
5, transformation and selection will be attached after the SpeI digestion of linear fragment 2 and goes out positive recombinant and carry out plasmid extraction, obtain Obtain pTarget T1-2 plasmid;Transformation and selection being attached after the SpeI digestion of linear fragment 3 and going out positive recombinant carry out matter Grain extracting, obtains pTarget T1-3 plasmid;Go out positive restructuring for transformation and selection is attached after the SpeI digestion of linear fragment 4 Son carries out plasmid extraction, obtains pTarget T1-4 plasmid;Go out transformation and selection is attached after the SpeI digestion of linear fragment 5 Positive recombinant carries out plasmid extraction, obtains pTarget T1-5 plasmid;It will be attached and turn after the SpeI digestion of linear fragment 6 Change filters out positive recombinant and carries out plasmid extraction, obtains pTarget T1-6 plasmid;
6, it is arranged with nucleotides sequence shown in SEQ ID NO:17 and SEQ ID NO:18 as primer, genome of E.coli is Template, PCR amplification obtain linear fragment 7;It is arranged with nucleotides sequence shown in SEQ ID NO:19 and SEQ ID NO:20 as primer, Genome of E.coli is template, and PCR amplification obtains linear fragment 8;
7, arranged with nucleotides sequence shown in SEQ ID NO:17 and SEQ ID NO:20 as primer, segment 7 and segment 8 it is mixed Conjunction object is template, and over-lap PCR expands to obtain linear fragment 9;
8, dephosphorylation carries out Ji Busen with segment 9 as carrier after using EcoRI to linearize pTarget T1-1 plasmid One-step cloning selects positive recombinant with the LB flat screen of spectinomycin;
9, numerous rear progress plasmid extraction is expanded into the LB liquid training that the positive recombinant in step 8 is inoculated in addition spectinomycin, Obtain pTarget T2-1 plasmid;
It 10, is that primer repeats step 6 to step 9 with the column of nucleotides sequence shown in SEQ ID NO:21-SEQ ID NO:24 Obtain pTarget T2-2 plasmid;It is that primer repeats to walk with the column of nucleotides sequence shown in SEQ ID NO:25-SEQ ID NO:28 Rapid 6 to step 9 obtain pTarget T2-3 plasmid;It is with the column of nucleotides sequence shown in SEQ ID NO:29-SEQ ID NO:32 Primer repeats step 6 to step 9 and obtains pTarget T2-4 plasmid;With core shown in SEQ ID NO:33-SEQ ID NO:36 Nucleotide sequence is that primer repeats step 6 to step 9 acquisition pTarget T2-5 plasmid;With SEQ ID NO:37-SEQ ID NO: Nucleotides sequence shown in 40 is classified as primer and repeats step 6 to step 9 acquisition pTarget T2-6 plasmid.
Embodiment 2
This example demonstrates that the method for inducing the preparation competence of albumen containing cas9 using arabinose, specific steps include:
1, pCas plasmid is imported into the Escherichia coli recombinant strain to gene editing, the biomaterial is in Chinese patent (application Numbers 201811346790.3, applying date 2018.11.13) patent document in disclose, deposit number is CCTCC NO:M 2018521, positive recombinant is selected with the LB flat screen of kanamycins;
2, the arabinose of 30mM of the positive recombinant in above-mentioned steps is induced, bacterium culture 3- is shaken in 30 DEG C of environment 4 hours, OD value about 0.4~0.6 was prepared as competence.
Embodiment 3
This example demonstrates that knocking out parental E. coli fumarase encoding gene using CRISPR/Cas9 technology FumABC, DNA transcription combine regulatory factor encoding gene arcA, glucose transport related gene ptsG, citrate synthase coding The process of gene gltA and argininosuccinate synthetase encoding gene argG.
1, pTarget T2-1 plasmid is imported in the competence of albumen containing cas9, with adding spectinomycin and kanamycins LB flat screen selects positive recombinant.
2, positive recombinant among the above is identified with the method for PCR, filters out aimed strain.
3, the bacterial strain 1 filtered out in step 2 is transferred in the LB culture medium containing kanamycins for being added to IPTG induction and is trained After supporting, LB culture medium flat plate of the turning point extremely containing kanamycins and the LB culture medium containing kanamycins and spectinomycin simultaneously are flat respectively Plate filters out the recombinant bacterial strain 1 for having degraded pTarget T2-1 plasmid.
4, the recombinant bacterial strain for filtering out step 3 is induced with arabinose, is prepared as competence.
5, by the competence of pTarget T2-2 plasmid steps for importing 4, with the LB of addition spectinomycin and kanamycins Flat screen selects positive recombinant.
6, positive recombinant among the above is identified with the method for PCR, filters out aimed strain.
7, the bacterial strain 2 filtered out in step 6 is transferred in the LB culture medium containing kanamycins for being added to IPTG induction and is trained After supporting, LB culture medium flat plate of the turning point extremely containing kanamycins and the LB culture medium containing kanamycins and spectinomycin simultaneously are flat respectively Plate filters out the recombinant bacterial strain 2 for having degraded pTarget T2-2 plasmid.
8, with the method for similar step 5 to step 7 import in batches pTarget T2-3 plasmid, pTarget T2-4 plasmid, PTarget T2-5 plasmid, pTarget T2-6 plasmid carry out gene knockout, and are eliminated using IPTG induction and import plasmid, obtain Gene knock-out bacterial strain Escherichia coli △ fumABC △ arcA △ ptsG △ gltA △ argG.
Embodiment 4
This example demonstrates that building and the Escherichia coli △ fumABC/ of pTrc99A-asnA-aspA plasmid PTrc99A-asnA-aspA genetic engineering bacterium screening process.
1, it is arranged with nucleotides sequence shown in SEQ ID NO:41 and SEQ ID NO:42 as primer, genome of E.coli is Template, PCR amplification obtain linear fragment 10;It is to draw with the column of nucleotides sequence shown in SEQ ID NO:43 and SEQ ID NO:44 Object, genome of E.coli are template, and PCR amplification obtains linear fragment 11;
2, it is arranged with nucleotides sequence shown in SEQ ID NO:41 and SEQ ID NO:44 as primer, segment 10 and segment 11 Mixture is template, and over-lap PCR expands to obtain linear fragment 12;
3, dephosphorylation is carried out as carrier with segment 11 after using EcoRI and HindIII to linearize pTrc99a plasmid Ji Busen one-step cloning selects positive recombinant with the LB flat screen of the resistance of benzyl containing ammonia;
4, numerous rear progress plasmid extraction is expanded into the LB liquid training that the positive recombinant in step 3 is inoculated in addition spectinomycin, Obtain pTrc99A-asnA-aspA recombinant plasmid;
5, bacterial strain Escherichia coli △ fumABC △ arcA △ ptsG △ gltA △ argG is prepared as experiencing State;PTrc99A-asnA-aspA plasmid in step 4 is converted into competence, is selected with the LB flat screen of the resistance of benzyl containing ammonia Positive recombinant obtains target gene engineered strain.
Embodiment 5
This example demonstrates that improving altheine yield and related enzyme activity data comparison using aerobic fermentation.Specific step It is rapid as follows:
1, using LB culture medium by 1~2% (v/v) inoculum concentration from cryopreservation tube access triangular flask in, it is aerobic culture 10~ 12h is further seeded to seed fermentation tank (culture medium is also LB) by 1~2% (v/v) inoculum concentration, to thallus after 4~6h of culture Between OD600 to 2.5~4, by 5~10% inoculation induced mediums (M9 culture medium, IPTG induction), mended after induction period Add glucose 30g/L;
2, the control of seed culture process temperature is not required to adjust pH at 35~37 DEG C, in culture.Fermentation process uses aerobic hair Ferment mode, dissolved oxygen are 5~40%, and at 28~30 DEG C, incubation pH is controlled with ammonium hydroxide 7.0 the control of fermentation process temperature. Fermentation the results are shown in Table 1 for 36 hours, and starting strain and recombinant bacterial strain enzyme activity comparison result are shown in Table 2.
1 two kinds of strain fermentations of table produce altheine situation
From upper table as it can be seen that in the identical situation of fermentation condition, recombinant bacterial strain is mentioned than the altheine yield of starting strain It is high by 29.4%.
2 two kinds of bacterial strain enzyme activity of table compare
Bacterial strain Sample time (h) Aspartase (U/mL) Asparagine synthetase A (U/mL)
Starting strain 5 70.6 64.1
Recombinant bacterial strain 5 988.2 907.1
Sequence table
<110>Nanjing University of Technology
<120>one plants of genetic engineering bacteriums for synthesizing altheine and its construction method and application
<130> xb19052103
<160> 44
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1647
<212> DNA
<213>the fumA gene order () knocked out
<400> 1
atgtcaaaca aaccctttca ttatcaggct ccttttccac tcaaaaaaga tgatactgag 60
tattacctgc taaccagcga acacgttagc gtatctgaat ttgaagggca ggagattttg 120
aaagtcgcac ccgaagcgtt aactctgttg gcgcgccagg cgtttcatga tgcgtcgttc 180
atgctgcgtc cggcgcacca acaacaggtg gccgacattc tgcgtgaccc ggaggccagc 240
gaaaatgata aatatgtggc gctgcaattc ctgcgtaact ccgacatcgc ggcgaaaggc 300
gttctgccaa cctgtcagga taccggcacc gcgattattg ttggtaaaaa agggcagcgt 360
gtatggaccg gtggtggtga tgaagcggcg ctggcgcgcg gtgtctataa cacttatatc 420
gaagataatc tgcgctactc gcaaaacgcg ccgctggata tgtataaaga agtgaatacc 480
ggcaccaatc tgccagcgca gatcgatctt tatgccgttg atggcgacga atacaaattc 540
ctctgtatcg ccaaaggtgg tggttcggca aacaagacgt atctctatca ggaaaccaaa 600
gcgttactga cgccggggaa actgaaaaat tacctggttg agaagatgcg cacgctgggt 660
acggcggcct gtcctccgta tcatattgcg ttcgttattg gtggaacttc tgcagaaacg 720
aaccttaaaa cggtgaaact ggcttccgcg aaatactatg atgaactgcc aacggaaggg 780
aatgagcacg gtcaggcgtt ccgcgatgtg gaactggaaa aagaattgct gatcgaagcg 840
caaaatcttg gtctgggtgc gcagtttggt ggtaaatact tcgctcacga catccgcgtg 900
attcgcctgc cacgtcacgg cgcatcctgc ccggtcggta tgggcgtctc ctgctctgct 960
gaccgtaata tcaaagcgaa gatcaaccgt caggggatct ggatcgaaaa actggaacat 1020
aatccaggca aatatatccc ggaagagctg cgcaaagcgg gagaaggcga agcggtgcgc 1080
gttgacctta accgtccgat gaaagagatc ctcgcacagt tgtcgcagta tcccgtttct 1140
acacgcttat cgcttaacgg cacgattatc gtcggtcgtg atattgctca cgccaaactg 1200
aaagagcgga tggataacgg tgaagggctg ccgcagtaca tcaaagatca tccgatttac 1260
tacgcgggtc cggccaaaac gccggaaggt tatgcctccg gttctcttgg cccaacgacc 1320
gccggacgga tggattctta tgtcgatcaa ctgcaagcgc agggcggaag tatgatcatg 1380
ctggcgaaag gcaaccgcag ccagcaggtg acggatgcct gtaaaaaaca cggcggcttc 1440
taccttggca gtatcggtgg tccggccgct gtattggcgc agggaagtat taagagcctg 1500
gaatgtgttg aatatccgga actgggaatg gaagccatct ggaaaattga agtggaagat 1560
ttcccggcgt ttatccttgt ggatgataaa ggaaatgact tcttccagca gatacaactc 1620
acacaatgca cccgctgtgt gaaataa 1647
<210> 2
<211> 1647
<212> DNA
<213>the fumB gene order () knocked out
<400> 2
atgtcaaaca aaccctttat ctaccaggca cctttcccga tggggaaaga caataccgaa 60
tactatctac tcacttccga ttacgttagc gttgccgact tcgacggcga aaccatcctg 120
aaagtggaac cagaagccct gaccctgctg gcgcagcaag cctttcacga cgcttctttt 180
atgctccgcc cggcacacca gaaacaggtt gcggctattc ttcacgatcc agaagccagc 240
gaaaacgaca agtacgtggc gctgcaattc ttaagaaact ccgaaatcgc cgccaaaggc 300
gtgctgccga cctgccagga taccggcacc gcgatcatcg tcggtaaaaa aggccagcgc 360
gtgtggaccg gcggcggtga tgaagaaacg ctgtcgaaag gcgtctataa cacctatatc 420
gaagataacc tgcgctattc acagaatgcg gcgctggaca tgtacaaaga ggtcaacacc 480
ggcactaacc tgcctgcgca aatcgacctg tacgcggtag atggcgatga gtacaaattc 540
ctttgcgttg cgaaaggcgg cggctctgcc aacaaaacgt atctctacca ggaaaccaaa 600
gccctgctga ctcccggcaa actgaaaaac ttcctcgtcg agaaaatgcg taccctcggt 660
actgcagcct gcccgccgta ccatatcgcg tttgtgattg gcggtacgtc tgcggaaacc 720
aacctgaaaa ccgtcaagtt agcaagcgct cactattacg atgaactgcc gacggaaggg 780
aacgaacatg gtcaggcgtt ccgcgatgtc cagctggaac aggaactgct ggaagaggcc 840
cagaaactcg gtcttggcgc gcagtttggc ggtaaatact tcgcgcacga cattcgcgtt 900
atccgtctgc cacgtcacgg cgcatcctgc ccggtcggca tgggcgtctc ctgctccgct 960
gaccgtaaca ttaaagcgaa aatcaaccgc gaaggtatct ggatcgaaaa actggaacac 1020
aacccaggcc agtacattcc acaagaactg cgccaggccg gtgaaggcga agcggtgaaa 1080
gttgacctta accgcccgat gaaagagatc ctcgcccagc tttcgcaata cccggtatcc 1140
actcgtttgt cgctcaccgg caccattatc gtgggccgag atattgcaca cgccaagctg 1200
aaagagctga ttgacgccgg taaagaactt ccgcagtaca tcaaagatca cccgatctac 1260
tacgcgggtc cggcgaaaac ccctgccggt tatccatcag gttcacttgg cccaaccacc 1320
gcaggccgta tggactccta cgtggatctg ctgcaatccc acggcggcag catgatcatg 1380
ctggcgaaag gtaaccgcag tcagcaggtt accgacgcgt gtcataaaca cggcggcttc 1440
tacctcggta gcatcggcgg tccggcggcg gtactggcgc agcagagcat caagcatctg 1500
gagtgcgtcg cttatccgga gctgggtatg gaagctatct ggaaaatcga agtagaagat 1560
ttcccggcgt ttatcctggt cgatgacaaa ggtaacgact tcttccagca aatcgtcaac 1620
aaacagtgcg cgaactgcac taagtaa 1647
<210> 3
<211> 1404
<212> DNA
<213>the fumC gene order () knocked out
<400> 3
atgaatacag tacgcagcga aaaagattcg atgggggcga ttgatgtccc ggcagataag 60
ctgtggggcg cacaaactca acgctcgctg gagcatttcc gcatttcgac ggagaaaatg 120
cccacctcac tgattcatgc gctggcgcta accaagcgtg cagcggcaaa agttaatgaa 180
gatttaggct tgttgtctga agagaaagcg agcgccattc gtcaggcggc ggatgaagta 240
ctggcaggac agcatgacga cgaattcccg ctggctatct ggcagaccgg ctccggcacg 300
caaagtaaca tgaacatgaa cgaagtgctg gctaaccggg ccagtgaatt actcggcggt 360
gtgcgcggga tggaacgtaa agttcaccct aacgacgacg tgaacaaaag ccaaagttcc 420
aacgatgtct ttccgacggc gatgcacgtt gcggcgctgc tggcgctgcg caagcaactc 480
attcctcagc ttaaaaccct gacacagaca ctgaatgaga aatcccgtgc ttttgccgat 540
atcgtcaaaa ttggtcgtac tcacttgcag gatgccacgc cgttaacgct ggggcaggag 600
atttccggct gggtagcgat gctcgagcat aatctcaaac atatcgaata cagcctgcct 660
cacgtagcgg aactggctct tggcggtaca gcggtgggta ctggactaaa tacccatccg 720
gagtatgcgc gtcgcgtagc agatgaactg gcagtcatta cctgtgcacc gtttgttacc 780
gcgccgaaca aatttgaagc gctggcgacc tgtgatgccc tggttcaggc gcacggcgcg 840
ttgaaagggt tggctgcgtc actgatgaaa atcgccaatg atgtccgctg gctggcctct 900
ggcccgcgct gcggaattgg tgaaatctca atcccggaaa atgagccggg cagctcaatc 960
atgccgggga aagtgaaccc aacacagtgt gaggcattaa ccatgctctg ctgtcaggtg 1020
atggggaacg acgtggcgat caacatgggg ggcgcttccg gtaactttga actgaacgtc 1080
ttccgtccaa tggtgatcca caatttcctg caatcggtgc gcttgctggc agatggcatg 1140
gaaagtttta acaaacactg cgcagtgggt attgaaccga atcgtgagcg aatcaatcaa 1200
ttactcaatg aatcgctgat gctggtgact gcgcttaaca cccacattgg ttatgacaaa 1260
gccgccgaga tcgccaaaaa agcgcataaa gaagggctga ccttaaaagc tgcggccctt 1320
gcgctggggt atcttagcga agccgagttt gacagctggg tacggccaga acagatggtc 1380
ggcagtatga aagccgggcg ttaa 1404
<210> 4
<211> 1437
<212> DNA
<213>aspA gene order ()
<400> 4
atgtcaaaca acattcgtat cgaagaagat ctgttgggta ccagggaagt tccagctgat 60
gcctactatg gtgttcacac tctgagagcg attgaaaact tctatatcag caacaacaaa 120
atcagtgata ttcctgaatt tgttcgcggt atggtaatgg ttaaaaaagc cgcagctatg 180
gcaaacaaag agctgcaaac cattcctaaa agtgtagcga atgccatcat tgccgcatgt 240
gatgaagtcc tgaacaacgg aaaatgcatg gatcagttcc cggtagacgt ctaccagggc 300
ggcgcaggta cttccgtaaa catgaacacc aacgaagtgc tggccaatat cggtctggaa 360
ctgatgggtc accaaaaagg tgaatatcag tacctgaacc cgaacgacca tgttaacaaa 420
tgtcagtcca ctaacgacgc ctacccgacc ggtttccgta tcgcagttta ctcttccctg 480
attaagctgg tagatgcgat taaccaactg cgtgaaggct ttgaacgtaa agctgtcgaa 540
ttccaggaca tcctgaaaat gggtcgtacc cagctgcagg acgcagtacc gatgaccctc 600
ggtcaggaat tccgcgcttt cagcatcctg ctgaaagaag aagtgaaaaa catccaacgt 660
accgctgaac tgctgctgga agttaacctt ggtgcaacag caatcggtac tggtctgaac 720
acgccgaaag agtactctcc gctggcagtg aaaaaactgg ctgaagttac tggcttccca 780
tgcgtaccgg ctgaagacct gatcgaagcg acctctgact gcggcgctta tgttatggtt 840
cacggcgcgc tgaaacgcct ggctgtgaag atgtccaaaa tctgtaacga cctgcgcttg 900
ctctcttcag gcccacgtgc cggcctgaac gagatcaacc tgccggaact gcaggcgggc 960
tcttccatca tgccagctaa agtaaacccg gttgttccgg aagtggttaa ccaggtatgc 1020
ttcaaagtca tcggtaacga caccactgtt accatggcag cagaagcagg tcagctgcag 1080
ttgaacgtta tggagccggt cattggccag gccatgttcg aatccgttca cattctgacc 1140
aacgcttgct acaacctgct ggaaaaatgc attaacggca tcactgctaa caaagaagtg 1200
tgcgaaggtt acgtttacaa ctctatcggt atcgttactt acctgaaccc gttcatcggt 1260
caccacaacg gtgacatcgt gggtaaaatc tgtgccgaaa ccggtaagag tgtacgtgaa 1320
gtcgttctgg aacgcggtct gttgactgaa gcggaacttg acgatatttt ctccgtacag 1380
aatctgatgc acccggctta caaagcaaaa cgctatactg atgaaagcga acagtaa 1437
<210> 5
<211> 993
<212> DNA
<213>asnA gene order ()
<400> 5
atgaaaaccg cttacattgc caaacaacgt caaattagct tcgtgaaatc tcacttttct 60
cgtcaactgg aagaacgtct ggggctgatc gaagtccagg cgccgattct tagccgtgtg 120
ggggatggca cgcaggataa cttgtcgggc tgtgaaaaag cggtgcaggt aaaagtgaaa 180
gctctgcctg atgcccagtt cgaagtggtt cattcactgg cgaagtggaa acgtcagacc 240
ttagggcaac acgacttcag cgcgggcgaa gggctgtaca cgcacatgaa agcccttcgc 300
cccgatgaag accgtctttc tccgttgcac tcggtctatg ttgaccagtg ggactgggaa 360
cgcgtaatgg gcgacggtga gcgtcaattc tcgactctga aaagcacggt agaggcgatc 420
tgggcgggaa ttaaagcaac cgaagctgcg gttagcgaag agtttggcct ggcaccgttc 480
ctgccggatc agatccactt cgtacacagc caggagttac tgtctcgtta tccggatctt 540
gatgccaaag ggcgtgagcg ggcgatagcg aaagatcttg gcgcggtatt ccttgtcggg 600
attggcggca agctgagcga tggtcatcgc cacgacgtgc gcgcaccgga ttatgatgac 660
tggagcaccc cgtcagagct gggccatgcg ggtctgaacg gcgatattct ggtgtggaac 720
ccggtactgg aagatgcgtt tgagctttcc tccatgggga tccgtgtaga tgccgacacg 780
ctgaagcatc aactggcgct gaccggtgac gaagatcgcc tggagctgga gtggcatcag 840
gcgctgctgc gcggtgaaat gccgcagacc atcggcggcg gtatcggcca gtctcgtttg 900
actatgctgc tgctgcaact gccgcatatc ggccaggttc agtgtggagt atggccagct 960
gctgttcgcg agagcgtccc ttctctgctg taa 993
<210> 6
<211> 717
<212> DNA
<213>the arcA gene order () knocked out
<400> 6
atgcagaccc cgcacattct tatcgttgaa gacgagttgg taacacgcaa cacgttgaaa 60
agtattttcg aagcggaagg ctatgatgtt ttcgaagcga cagatggcgc ggaaatgcat 120
cagatcctct ctgaatatga catcaacctg gtgatcatgg atatcaatct gccgggtaag 180
aacggtcttc tgttagcgcg tgaactgcgc gagcaggcga atgttgcgtt gatgttcctg 240
actggccgtg acaacgaagt cgataaaatt ctcggcctcg aaatcggtgc agatgactac 300
atcaccaaac cgttcaaccc gcgtgaactg acgattcgtg cacgcaacct actgtcccgt 360
accatgaatc tgggtactgt cagcgaagaa cgtcgtagcg ttgaaagcta caagttcaat 420
ggttgggaac tggacatcaa cagccgttcg ttgatcggcc ctgatggcga gcagtacaag 480
ctgccgcgca gcgagttccg cgccatgctt cacttctgtg aaaacccagg caaaattcag 540
tcccgtgctg aactgctgaa gaaaatgacc ggccgtgagc tgaaaccgca cgaccgtact 600
gtagacgtga cgatccgccg tattcgtaaa catttcgaat ctacgccgga tacgccggaa 660
atcatcgcca ccattcacgg tgaaggttat cgcttctgcg gtgatctgga agattaa 717
<210> 7
<211> 1434
<212> DNA
<213>the ptsG gene order () knocked out
<400> 7
atgtttaaga atgcatttgc taacctgcaa aaggtcggta aatcgctgat gctgccggta 60
tccgtactgc ctatcgcagg tattctgctg ggcgtcggtt ccgcgaattt cagctggctg 120
cccgccgttg tatcgcatgt tatggcagaa gcaggcggtt ccgtctttgc aaacatgcca 180
ctgatttttg cgatcggtgt cgccctcggc tttaccaata acgatggcgt atccgcgctg 240
gccgcagttg ttgcctatgg catcatggtt aaaaccatgg ccgtggttgc gccactggta 300
ctgcatttac ctgctgaaga aatcgcctct aaacacctgg cggatactgg cgtactcgga 360
gggattatct ccggtgcgat cgcagcgtac atgtttaacc gtttctaccg tattaagctg 420
cctgagtatc ttggcttctt tgccggtaaa cgctttgtgc cgatcatttc tggcctggct 480
gccatcttta ctggcgttgt gctgtccttc atttggccgc cgattggttc tgcaatccag 540
accttctctc agtgggctgc ttaccagaac ccggtagttg cgtttggcat ttacggtttc 600
atcgaacgtt gcctggtacc gtttggtctg caccacatct ggaacgtacc tttccagatg 660
cagattggtg aatacaccaa cgcagcaggt caggttttcc acggcgacat tccgcgttat 720
atggcgggtg acccgactgc gggtaaactg tctggtggct tcctgttcaa aatgtacggt 780
ctgccagctg ccgcaattgc tatctggcac tctgctaaac cagaaaaccg cgcgaaagtg 840
ggcggtatta tgatctccgc ggcgctgacc tcgttcctga ccggtatcac cgagccgatc 900
gagttctcct tcatgttcgt tgcgccgatc ctgtacatca tccacgcgat tctggcaggc 960
ctggcattcc caatctgtat tcttctgggg atgcgtgacg gtacgtcgtt ctcgcacggt 1020
ctgatcgact tcatcgttct gtctggtaac agcagcaaac tgtggctgtt cccgatcgtc 1080
ggtatcggtt atgcgattgt ttactacacc atcttccgcg tgctgattaa agcactggat 1140
ctgaaaacgc cgggtcgtga agacgcgact gaagatgcaa aagcgacagg taccagcgaa 1200
atggcaccgg ctctggttgc tgcatttggt ggtaaagaaa acattactaa cctcgacgca 1260
tgtattaccc gtctgcgcgt cagcgttgct gatgtgtcta aagtggatca ggccggcctg 1320
aagaaactgg gcgcagcggg cgtagtggtt gctggttctg gtgttcaggc gattttcggt 1380
actaaatccg ataacctgaa aaccgagatg gatgagtaca tccgtaacca ctaa 1434
<210> 8
<211> 1284
<212> DNA
<213>the gltA gene order () knocked out
<400> 8
atggctgata caaaagcaaa actcaccctc aacggggata cagctgttga actggatgtg 60
ctgaaaggca cgctgggtca agatgttatt gatatccgta ctctcggttc aaaaggtgtg 120
ttcacctttg acccaggctt cacttcaacc gcatcctgcg aatctaaaat tacttttatt 180
gatggtgatg aaggtatttt gctgcaccgc ggtttcccga tcgatcagct ggcgaccgat 240
tctaactacc tggaagtttg ttacatcctg ctgaatggtg aaaaaccgac tcaggaacag 300
tatgacgaat ttaaaactac ggtgacccgt cataccatga tccacgagca gattacccgt 360
ctgttccatg ctttccgtcg cgactcgcat ccaatggcag tcatgtgtgg tattaccggc 420
gcgctggcgg cgttctatca cgactcgctg gatgttaaca atcctcgtca ccgtgaaatt 480
gccgcgttcc gcctgctgtc gaaaatgccg accatggccg cgatgtgtta caagtattcc 540
attggtcagc catttgttta cccgcgcaac gatctctcct acgccggtaa cttcctgaat 600
atgatgttct ccacgccgtg cgaaccgtat gaagttaatc cgattctgga acgtgctatg 660
gaccgtattc tgatcctgca cgctgaccat gaacagaacg cctctacctc caccgtgcgt 720
accgctggct cttcgggtgc gaacccgttt gcctgtatcg cagcaggtat tgcttcactg 780
tggggacctg cgcacggcgg tgctaacgaa gcggcgctga aaatgctgga agaaatcagc 840
tccgttaaac acattccgga atttgttcgt cgtgcgaaag acaaaaatga ttctttccgc 900
ctgatgggct tcggtcaccg cgtgtacaaa aattacgacc cgcgcgccac cgtaatgcgt 960
gaaacctgcc atgaagtgct gaaagagctg ggcacgaagg atgacctgct ggaagtggct 1020
atggagctgg aaaacatcgc gctgaacgac ccgtacttta tcgagaagaa actgtacccg 1080
aacgtcgatt tctactctgg tatcatcctg aaagcgatgg gtattccgtc ttccatgttc 1140
accgtcattt tcgcaatggc acgtaccgtt ggctggatcg cccactggag cgaaatgcac 1200
agtgacggta tgaagattgc ccgtccgcgt cagctgtata caggatatga aaaacgcgac 1260
tttaaaagcg atatcaagcg ttaa 1284
<210> 9
<211> 1344
<212> DNA
<213>the argG gene order () knocked out
<400> 9
atgacgacga ttctcaagca tctcccggta ggtcaacgta ttggtatcgc tttttctggc 60
ggtctggaca ccagtgccgc actgctgtgg atgcgacaaa agggagcggt tccttatgca 120
tatactgcaa acctgggcca gccagacgaa gaggattatg atgcgatccc tcgtcgtgcc 180
atggaatacg gcgcggagaa cgcacgtctg atcgactgcc gcaaacaact ggtggccgaa 240
ggtattgccg ctattcagtg tggcgcattt cataacacca ccggcggcct gacctatttc 300
aacacgacgc cgctgggccg cgccgtgact ggtaccatgc tggttgctgc gatgaaagaa 360
gatggcgtga atatctgggg tgacggtagc acctacaaag gaaacgatat cgaacgtttc 420
tatcgttatg gtctgctgac caatgctgaa ctgcagattt acaaaccgtg gcttgatact 480
gactttattg atgaactggg cggccgtcat gagatgtctg aatttatgat tgcctgcggt 540
ttcgactaca aaatgtctgt cgaaaaagcc tactccacag actccaacat gcttggtgca 600
acgcatgaag cgaaggatct ggaatacctc aactccagcg tcaaaatcgt caacccgatt 660
atgggcgtga aattctggga tgagagcgtg aagatcccgg cagaagaagt cacagtacgc 720
tttgaacaag gtcatccggt ggcgctgaac ggtaaaacct ttagcgacga cgtagaaatg 780
atgctggaag ctaaccgcat cggcggtcgt cacggcctgg gcatgagcga ccagattgaa 840
aaccgtatca tcgaagcgaa aagccgtggt atttacgaag ctccggggat ggcactgctg 900
cacattgcgt atgaacgcct gttgaccggt attcacaacg aagacaccat tgagcagtat 960
cacgcgcatg gtcgtcagtt gggccgtctg ctgtaccagg ggcgttggtt tgactcccag 1020
gcgctgatgc tgcgtgactc tctgcaacgc tgggttgcca gccagatcac tggtgaagtt 1080
accctggagc tgcgccgtgg gaacgattat tcaatcctga ataccgtctc agagaacctg 1140
acctacaagc cagagcgtct gacgatggaa aaaggcgact cggtgttctc gccagatgat 1200
cgtattggtc aattgaccat gcgtaacctg gatatcactg atacccgcga gaaacttttc 1260
ggttatgcca aaactggcct gctttcctcc tctgccgctt caggcgtgcc gcaggtggag 1320
aatctggaaa acaaaggcca gtaa 1344
<210> 10
<211> 28
<212> DNA
<213>amplimer sequence F ()
<400> 10
gatgactagt attataccta ggactgag 28
<210> 11
<211> 53
<212> DNA
<213>amplimer sequence R ()
<400> 11
ctagactagt atactatgat gaactgccaa gttttagagc tagaaatagc aag 53
<210> 12
<211> 53
<212> DNA
<213>amplimer sequence R ()
<400> 12
ctagactagt gtgagcgctt gctaacttga gttttagagc tagaaatagc aag 53
<210> 13
<211> 53
<212> DNA
<213>amplimer sequence R ()
<400> 13
ctagactagt actgtcccgt accatgaatc gttttagagc tagaaatagc aag 53
<210> 14
<211> 53
<212> DNA
<213>amplimer sequence R ()
<400> 14
ctagactagt gcgctgacct cgttcctgac gttttagagc tagaaatagc aag 53
<210> 15
<211> 53
<212> DNA
<213>amplimer sequence R ()
<400> 15
ctagactagt gcaggtattg cttcactgtg gttttagagc tagaaatagc aag 53
<210> 16
<211> 53
<212> DNA
<213>amplimer sequence R ()
<400> 16
ctagactagt gtggtattta cgaagctccg gttttagagc tagaaatagc aag 53
<210> 17
<211> 35
<212> DNA
<213>amplimer sequence F ()
<400> 17
gctttttttg aattctggat gaacctgaat ggaga 35
<210> 18
<211> 41
<212> DNA
<213>amplimer sequence R ()
<400> 18
ctgcacctgt atgttgcaga tgttctctca cttactgcct g 41
<210> 19
<211> 41
<212> DNA
<213>amplimer sequence F ()
<400> 19
caggcagtaa gtgagagaac atctgcaaca tacaggtgca g 41
<210> 20
<211> 31
<212> DNA
<213>amplimer sequence R ()
<400> 20
gatctaagct tatgggtgca tcgtcatttg c 31
<210> 21
<211> 35
<212> DNA
<213>amplimer sequence F ()
<400> 21
gctttttttg aattcatcgc catcgtggcg gtgta 35
<210> 22
<211> 42
<212> DNA
<213>amplimer sequence R ()
<400> 22
ccaggcgctg ggccgaagag gagcttccag cctgtaactc tg 42
<210> 23
<211> 42
<212> DNA
<213>amplimer sequence F ()
<400> 23
cagagttaca ggctggaagc tcctcttcgg cccagcgcct gg 42
<210> 24
<211> 31
<212> DNA
<213>amplimer sequence R ()
<400> 24
gatctaagct tttacgtccg cgcacgtaca t 31
<210> 25
<211> 35
<212> DNA
<213>amplimer sequence F ()
<400> 25
gctttttttg aattcgactg tactaacggt tgagt 35
<210> 26
<211> 40
<212> DNA
<213>amplimer sequence R ()
<400> 26
tttgacggtg gtaaagccga gtttgctacc taaattgcca 40
<210> 27
<211> 40
<212> DNA
<213>amplimer sequence F ()
<400> 27
tggcaattta ggtagcaaac tcggctttac caccgtcaaa 40
<210> 28
<211> 31
<212> DNA
<213>amplimer sequence R ()
<400> 28
gatctaagct tattctgctg attgcactga c 31
<210> 29
<211> 35
<212> DNA
<213>amplimer sequence F ()
<400> 29
gctttttttg aattcgatcg gttactggtg gaaac 35
<210> 30
<211> 40
<212> DNA
<213>amplimer sequence R ()
<400> 30
tctccccaac gtcttacgga aattgagagt gctcctgagt 40
<210> 31
<211> 40
<212> DNA
<213>amplimer sequence F ()
<400> 31
actcaggagc actctcaatt tccgtaagac gttggggaga 40
<210> 32
<211> 31
<212> DNA
<213>amplimer sequence R ()
<400> 32
gatctaagct tcagtaaagg ggtggaattt g 31
<210> 33
<211> 35
<212> DNA
<213>amplimer sequence F ()
<400> 33
gctttttttg aattcgttcc ggagacctgg cggca 35
<210> 34
<211> 42
<212> DNA
<213>amplimer sequence R ()
<400> 34
tttacaactt agcaatcaac cattaaggtc tccttagcgc ct 42
<210> 35
<211> 42
<212> DNA
<213>amplimer sequence F ()
<400> 35
aggcgctaag gagaccttaa tggttgattg ctaagttgta aa 42
<210> 36
<211> 31
<212> DNA
<213>amplimer sequence R ()
<400> 36
gatctaagct ttgaatttca caaggtgctt c 31
<210> 37
<211> 35
<212> DNA
<213>amplimer sequence F ()
<400> 37
gctttttttg aattcaatcc cactacgaag gccga 35
<210> 38
<211> 42
<212> DNA
<213>amplimer sequence R ()
<400> 38
agggcagggt tgatgtcgaa aaaataacac cctgcttaat ta 42
<210> 39
<211> 42
<212> DNA
<213>amplimer sequence F ()
<400> 39
taattaagca gggtgttatt ttttcgacat caaccctgcc ct 42
<210> 40
<211> 31
<212> DNA
<213>amplimer sequence R ()
<400> 40
gatctaagct ttccgcaatc cagcgccgtg t 31
<210> 41
<211> 41
<212> DNA
<213>amplimer sequence F ()
<400> 41
aggaaacaga ccatggaatt catgaaaacc gcttacattg c 41
<210> 42
<211> 52
<212> DNA
<213>amplimer sequence R ()
<400> 42
tttctacctc cttataaata gtttcctttt tacagcagag aagggacgct ct 52
<210> 43
<211> 54
<212> DNA
<213>amplimer sequence F ()
<400> 43
aaaggaaact atttataagg aggtagaaaa tgtcaaacaa cattcgtatc gaag 54
<210> 44
<211> 41
<212> DNA
<213>amplimer sequence R ()
<400> 44
tccgccaaaa cagccaagct tttactgttc gctttcatca g 41

Claims (8)

1. the genetic engineering bacterium of one plant of synthesis altheine, classification naming is Escherichia coli △ fumABC △ ArcA △ ptsG △ gltA △ argG/pAA, deposit number are CCTCC NO:M 2019170.
2. genetic engineering bacterium according to claim 1, which is characterized in that knockout deposit number is CCTCC NO:M 2018521 Starting strain fumarase encoding gene fumABC, DNA transcription combine regulatory factor encoding gene arcA, glucose transport related Gene ptsG, citrate synthase encoding gene gltA and argininosuccinate synthetase encoding gene argG, while by asparagus fern ammonia Sour enzyme coding gene aspA and asparagine synthetase A encoding gene asnA are cloned on expression plasmid and constitute recombinant plasmid, and It is converted to the Escherichia coli starting strain for having knocked out fumABC gene, obtains the genetic engineering bacterium, the fumA gene Sequence is as shown in SEQ ID NO:1, and the fumB gene order is as shown in SEQ ID NO:2, the fumC gene order such as SEQ Shown in ID NO:3, the aspA gene order is as shown in SEQ ID NO:4, the asnA gene order such as SEQ ID NO:5 institute Show, for the arcA gene order as shown in SEQ ID NO:6, the ptsG gene order is described as shown in SEQ ID NO:7 GltA gene order is as shown in SEQ ID NO:8, and the argG gene order is as shown in SEQ ID NO:9.
3. the construction method of genetic engineering bacterium described in claim 1, which comprises the steps of:
(1) it is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:11 as primer, plasmid pTarget F is mould Plate, PCR amplification obtain linear fragment 1;
(2) it is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:12 as primer, repeats step (1) and obtain linearly Segment 2;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:13 as primer, repeats step (1) and obtain linearly Segment 3;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:14 as primer, repeats step (1) and obtain linearly Segment 4;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:15 as primer, repeats step (1) and obtain linearly Segment 5;It is arranged with nucleotides sequence shown in SEQ ID NO:10 and SEQ ID NO:16 as primer, repeats step (1) and obtain linearly Segment 6;
(3) it will be attached after the SpeI digestion of linear fragment 1, and product after connection be transformed into competence, be coated with grand sight The LB flat screen of mycin selects positive recombinant;
(4) numerous rear progress plasmid extraction is expanded into the LB liquid training that positive recombinant is inoculated in addition spectinomycin, obtains pTarget T1-1 plasmid;
(5) it will be attached transformation and selection after the SpeI digestion of linear fragment 2 go out positive recombinant and carry out plasmid extraction, obtain PTarget T1-2 plasmid;Transformation and selection being attached after the SpeI digestion of linear fragment 3 and going out positive recombinant carry out plasmid Extracting obtains pTarget T1-3 plasmid;Go out positive recombinant for transformation and selection is attached after the SpeI digestion of linear fragment 4 Plasmid extraction is carried out, pTarget T1-4 plasmid is obtained;It will be attached transformation and selection after the SpeI digestion of linear fragment 5 and go out sun Property recon carry out plasmid extraction, obtain pTarget T1-5 plasmid;Conversion will be attached after the SpeI digestion of linear fragment 6 It filters out positive recombinant and carries out plasmid extraction, obtain pTarget T1-6 plasmid;
(6) it is arranged with nucleotides sequence shown in SEQ ID NO:17 and SEQ ID NO:18 as primer, genome of E.coli is mould Plate, PCR amplification obtain linear fragment 7;It is arranged for primer, greatly with nucleotides sequence shown in SEQ ID NO:19 and SEQ ID NO:20 Enterobacteria genome is template, and PCR amplification obtains linear fragment 8;
(7) mixing of segment 7 and segment 8 for primer is arranged with nucleotides sequence shown in SEQ ID NO:17 and SEQ ID NO:20 Object is template, and over-lap PCR expands to obtain linear fragment 9;
(8) dephosphorylation carries out lucky cloth gloomy one with segment 9 as carrier after using EcoRI to linearize pTarget T1-1 plasmid Step clone, selects positive recombinant with the LB flat screen of spectinomycin;
(9) numerous rear progress plasmid extraction is expanded into the LB liquid training that the positive recombinant in step (8) is inoculated in addition spectinomycin, obtains Obtain pTarget T2-1 plasmid;
It (10) is that primer repeats step (6) to step (9) with the column of nucleotides sequence shown in SEQ ID NO:21-SEQ ID NO:24 Obtain pTarget T2-2 plasmid;It is that primer repeats to walk with the column of nucleotides sequence shown in SEQ ID NO:25-SEQ ID NO:28 Suddenly (6) to step (9) obtain pTarget T2-3 plasmid;With nucleotides sequence shown in SEQ ID NO:29-SEQ ID NO:32 It is classified as primer and repeats step (6) to step (9) acquisition pTarget T2-4 plasmid;With SEQ ID NO:33-SEQ ID NO:36 Shown in nucleotides sequence be classified as primer repeat step (6) to step (9) obtain pTarget T2-5 plasmid;With SEQ ID NO: Nucleotides sequence shown in 37-SEQ ID NO:40 is classified as primer and repeats step (6) to step (9) acquisition pTarget T2-6 matter Grain;
(11) pCas plasmid is imported in the starting strain that deposit number is CCTCC NO:M 2018521, it is flat with the LB of kanamycins Screen selects positive recombinant;
(12) positive recombinant in step (11) is induced with arabinose, is prepared as competence;
(13) by the competence of pTarget T2-1 plasmid steps for importing (12), with the LB of addition spectinomycin and kanamycins Flat screen selects positive recombinant;
(14) positive recombinant in step (13) is identified with the method for PCR, filters out aimed strain, and use IPTG PTarget T2-1 plasmid is eliminated in induction, obtains bacterial strain 1;
(15) bacterial strain 1 in step (14) is induced with arabinose, is prepared as competence;
(16) by the competence of pTarget T2-2 plasmid steps for importing (15), with the LB of addition spectinomycin and kanamycins Flat screen selects positive recombinant;
(17) positive recombinant in step (16) is identified with the method for PCR, filters out aimed strain, and use IPTG PTarget T2-2 plasmid is eliminated in induction, obtains bacterial strain 2;
(18) pTarget T2-3 plasmid, pTarget T2-4 matter are imported in batches with the method for similar step (15) to step (17) Grain, pTarget T2-5 plasmid, pTarget T2-6 plasmid carry out gene knockout, and are eliminated using IPTG induction and import plasmid, Obtain gene knock-out bacterial strain Escherichia coli △ fumABC △ arcA △ ptsG △ gltA △ argG;
(19) it is arranged with nucleotides sequence shown in SEQ ID NO:41 and SEQ ID NO:42 as primer, genome of E.coli is mould Plate, PCR amplification obtain linear fragment 10;It is arranged with nucleotides sequence shown in SEQ ID NO:43 and SEQ ID NO:44 as primer, Genome of E.coli is template, and PCR amplification obtains linear fragment 11;
(20) arranged with nucleotides sequence shown in SEQ ID NO:41 and SEQ ID NO:44 as primer, segment 10 and segment 11 it is mixed Conjunction object is template, and over-lap PCR expands to obtain linear fragment 12;
(21) dephosphorylation carries out Ji with segment 11 as carrier after using EcoRI and HindIII to linearize pTrc99a plasmid The gloomy one-step cloning of cloth selects positive recombinant with the LB flat screen of the resistance of benzyl containing ammonia;
(22) numerous rear progress plasmid extraction is expanded into the LB liquid training that the positive recombinant in step (21) is inoculated in addition spectinomycin, Obtain pTrc99A-asnA-aspA plasmid;
(23) gene knock-out bacterial strain in step (18) is prepared as competence;By the pTrc99A-asnA- in step (22) AspA plasmid is converted into competence, is selected positive recombinant with the LB flat screen of the resistance of benzyl containing ammonia, is obtained target gene engineering Bacterial strain.
4. the genetic engineering bacterium for synthesizing altheine described in claim 1 prepares answering in altheine in biosynthesis With.
5. application according to claim 4, which is characterized in that the process for preparing altheine is as follows:
(S1) genetic engineering bacterium is transferred in LB culture medium, 10~12h of aerobic culture obtains primary seed solution;
(S2) primary seed solution is transferred in fermentor LB culture medium and is cultivated, obtain secondary seed solution;
(S3) to secondary seed solution OD600When to 8.5, induced medium is inoculated, the formula of the induced medium is as follows:
M9 culture medium: (NH4)2SO46g/L, Na2HPO4·12H2O 15.2g/L, KH2PO43g/L, NaCl 0.5g/L, NH4Cl 1g/L, MgSO42mM, CaCl20.1mM, 100g/L glucose, 0.3mM IPTG;
(S4) glucose 30g/L transformation stage fed-batch fermentation: is added after induction period.
6. application according to claim 5, which is characterized in that in step (S1) and (S2), cultivation temperature is 35~37 DEG C.
7. application according to claim 5, which is characterized in that in step (S3) and (S4), dissolved oxygen control 5~ 40%.
8. application according to claim 5, which is characterized in that temperature is 28~30 in step (S3) and (S4) fermentation process DEG C, incubation pH is adjusted to 7.0 with ammonium hydroxide.
CN201910425792.XA 2019-05-21 2019-05-21 One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application Pending CN110218691A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910425792.XA CN110218691A (en) 2019-05-21 2019-05-21 One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910425792.XA CN110218691A (en) 2019-05-21 2019-05-21 One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application

Publications (1)

Publication Number Publication Date
CN110218691A true CN110218691A (en) 2019-09-10

Family

ID=67821639

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910425792.XA Pending CN110218691A (en) 2019-05-21 2019-05-21 One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application

Country Status (1)

Country Link
CN (1) CN110218691A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114606253A (en) * 2022-03-14 2022-06-10 浙江工业大学 Recombinant escherichia coli capable of producing L-methionine at high yield without action of exogenous amino acid and application thereof
CN115247144A (en) * 2021-04-27 2022-10-28 中国科学院青岛生物能源与过程研究所 Genetically engineered bacterium for producing L-threo-3-hydroxyaspartic acid and application thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000197490A (en) * 1998-11-02 2000-07-18 Ajinomoto Co Inc Production of l-arginine
US20060063240A1 (en) * 2003-03-12 2006-03-23 Katashkina Joanna Y Method for producing an L-amino acid using a bacterium with an optimized level of gene expression
CN101405398A (en) * 2006-03-30 2009-04-08 味之素株式会社 Method for producing L-amino acid
CN104254606A (en) * 2012-01-11 2014-12-31 韩国科学技术院 Novel synthesis-regulating srna and method for preparing same
CN105925520A (en) * 2016-06-16 2016-09-07 南京工业大学 Recombinant escherichia coli efficiently transforming fumaric acid into L-asparagine as well as construction method and application thereof
CN107022515A (en) * 2017-05-19 2017-08-08 南京工业大学 One plant of genetic engineering bacterium and its construction method and application using ligno-cellulose hydrolysate anaerobic fermentation production L aspartic acids
CN107787361A (en) * 2015-03-20 2018-03-09 韩国科学技术院 Generate the mutant microbial of L aspartames and the method using mutant microbial generation L aspartames
CN108728470A (en) * 2017-04-14 2018-11-02 中国科学院微生物研究所 The recombinant bacterium and its construction method of production Beta-alanine and application
CN109370971A (en) * 2018-11-13 2019-02-22 南京工业大学 One plant of fermentation produces genetic engineering bacterium and its construction method and the application of L-Aspartic acid

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000197490A (en) * 1998-11-02 2000-07-18 Ajinomoto Co Inc Production of l-arginine
US20060063240A1 (en) * 2003-03-12 2006-03-23 Katashkina Joanna Y Method for producing an L-amino acid using a bacterium with an optimized level of gene expression
CN101405398A (en) * 2006-03-30 2009-04-08 味之素株式会社 Method for producing L-amino acid
CN104254606A (en) * 2012-01-11 2014-12-31 韩国科学技术院 Novel synthesis-regulating srna and method for preparing same
CN107787361A (en) * 2015-03-20 2018-03-09 韩国科学技术院 Generate the mutant microbial of L aspartames and the method using mutant microbial generation L aspartames
CN105925520A (en) * 2016-06-16 2016-09-07 南京工业大学 Recombinant escherichia coli efficiently transforming fumaric acid into L-asparagine as well as construction method and application thereof
CN108728470A (en) * 2017-04-14 2018-11-02 中国科学院微生物研究所 The recombinant bacterium and its construction method of production Beta-alanine and application
CN107022515A (en) * 2017-05-19 2017-08-08 南京工业大学 One plant of genetic engineering bacterium and its construction method and application using ligno-cellulose hydrolysate anaerobic fermentation production L aspartic acids
CN109370971A (en) * 2018-11-13 2019-02-22 南京工业大学 One plant of fermentation produces genetic engineering bacterium and its construction method and the application of L-Aspartic acid

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
REEVE BWP等: "Glutamate and histidine improve both solvent yields and the acid tolerance response of clostridium beijerinckii NCP260", 《JOURNAL OF APPLIED MICROBIOLOGY》 *
卢正珂等: "过表达mqo对重组谷氨酸棒杆菌L-异亮氨酸和4-羟基异亮氨酸合成的影响", 《食品与发酵工业》 *
孙小龙等: "C4二羧酸全生物合成技术的研究现状与展望", 《江苏农业科学》 *
张明阳等: "精氨酸代谢途径抗酸关键基因对乳酸乳球菌Lactococcus lactis NZ9000胁迫抗性的影响", 《微生物学通报》 *
徐虹等: "游离酶法生产L-天冬氨酸的工艺研究", 《南京化工大学学报(自然科学版)》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115247144A (en) * 2021-04-27 2022-10-28 中国科学院青岛生物能源与过程研究所 Genetically engineered bacterium for producing L-threo-3-hydroxyaspartic acid and application thereof
CN115247144B (en) * 2021-04-27 2023-07-11 中国科学院青岛生物能源与过程研究所 Genetically engineered bacterium for producing L-threo-3-hydroxy aspartic acid and application thereof
CN114606253A (en) * 2022-03-14 2022-06-10 浙江工业大学 Recombinant escherichia coli capable of producing L-methionine at high yield without action of exogenous amino acid and application thereof
CN114606253B (en) * 2022-03-14 2024-03-26 浙江工业大学 Recombinant escherichia coli capable of high yield of L-methionine under action of no exogenous amino acid and application thereof

Similar Documents

Publication Publication Date Title
US10975400B2 (en) 5-aminolevulinic acid high-yield bacterial strain, preparation method and use thereof
CN101240259B (en) Novel constructed high-yield fumaric acid gene engineering bacterium and method for producing fumaric acid thereby
US20230279456A1 (en) Genetically Engineered Bacteria Producing Lacto-N-neotetraose and Production Method Thereof
CN101173308A (en) Method for ferment for producing adenomethionine with genetic engineering bacterium
CN108753860A (en) The structure of Recombinant organism and its purposes of production L-Trp
CN106434510B (en) One plant of fermentation produces the genetic engineering bacterium of L-Aspartic acid
CN113430151B (en) Corynebacterium glutamicum and application thereof in fermentation production of L-valine
CN109370971A (en) One plant of fermentation produces genetic engineering bacterium and its construction method and the application of L-Aspartic acid
KR20100109902A (en) Large scale microbial culture method
CN107022515A (en) One plant of genetic engineering bacterium and its construction method and application using ligno-cellulose hydrolysate anaerobic fermentation production L aspartic acids
CN105593361A (en) Modified microorganism for improved production of alanine
CN105154381A (en) Novel mutant microorganism producing succinic acid simultaneously using sucrose and glycerol, and method for preparing succinic acid using same
CN106536717A (en) Genetically modified microorganism for improved production of fine chemicals on sucrose
CN110218691A (en) One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application
US11136596B2 (en) Long-chain dibasic acid with low content of hydroxyl acid impurity and production method thereof
CN106167772B (en) The Recombinant organism and its construction method of a kind of high yield pyruvic acid and application
CN104630100A (en) Reconstructed Klebsiella pneumoniae and application of reconstructed Klebsiella pneumoniae in production of R-acetoin
CN102399738B (en) Genetic engineering bacterium for producing succinic acid and method for producing succinic acid by fermentation of genetic engineering bacteria
CN106164249A (en) The modified microorganism that fine chemicals produces is improved for based on sucrose
CN113801834B (en) Gene engineering streptomyces diastatochromogenes for high yield of toyocamycin and construction method and application thereof
CN104017767A (en) Method for improving yield of 5-aminolevulinic acid by utilizing combined control strategy
CN109554321B (en) Genetically engineered bacterium for high-yield lipopeptide and application thereof
CN109097315B (en) Genetically engineered bacterium for high-yield lipopeptide and construction method and application thereof
CN101892228B (en) Engineering bacteria with high tolerance to acrylamide and acrylonitrile for producing nitrile hydratase and application thereof
CN110004102A (en) A kind of bacterial strain and method using maleic acid whole-cell catalytic synthesis L-Aspartic acid

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190910